| Dr Richard Kevin Roach, DO | |
|
Naval Hospital Camp Pendleton, Bldg H100,santa Margarita Road, Camp Pendleton, CA 92055 | |
| (760) 725-1620 | |
| Not Available |
| Full Name | Dr Richard Kevin Roach |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | Naval Hospital Camp Pendleton, Camp Pendleton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508858978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A7556 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Kevin Roach, DO 14251 Silver Ridge Rd, Poway, CA 92064-4969 Ph: (858) 748-6303 | Dr Richard Kevin Roach, DO Naval Hospital Camp Pendleton, Bldg H100,santa Margarita Road, Camp Pendleton, CA 92055 Ph: (760) 725-1620 |
News Archive
In a study published online in advance of print in Stem Cells, Tufts researchers report that the STAT3 gene regulates cancer stem cells in brain cancer. Cancer stem cells have many characteristics of stem cells and are thought to be the cells that drive tumor formation. The researchers report that STAT3 could become a target for cancer therapy, specifically in Glioblastoma multiforme (GBM), a type of malignant and aggressive brain tumor.
Watson Pharmaceuticals, Inc. today confirmed that Actavis South Atlantic LLC, which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Oxymorphone Hydrochloride Extended-release Tablets.
ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.
For the first time in this disease area, researchers at the SGI have identified 80 genes involved in the inflammatory and neuro-degenerative pathways of MS, based on a 40% genome scan comparing the genetic profile of a total of 1,800 people with MS and healthy individuals in different populations.
› Verified 9 days ago
Dr. Michael Andrew Galuska, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Building H100, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-725-1620 | |
Dr. Theomal Devinda Kurera, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Santa Margarita Road, Camp Pendleton, CA 92055 Phone: 760-725-1620 | |
Dr. Ed Hessel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1st Marine Division, Box 555380, Camp Pendleton, CA 92055 Phone: 760-725-5209 | |
Dr. Felipe Humberto Grimaldo Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Circle, Camp Pendleton, CA 92055 Phone: 760-725-1288 | |
Dr. Lisa Ann Kelty, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: H100 Santa Margerita Rd, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 904-343-4656 | |
Dr. Amy Marie Pritchard, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Mercy Circle, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-719-4966 |